FDA
-
-
-
-
-
-
-
PROCEPT BioRoboticsĀ® Advances Prostate Cancer Program with WATER IV Study Enrollment Completion and Expanded IDE Approval
-
-
-
-
-
-
-
Piper Sandler Reiterates Overweight Rating on Procept BioRobotics Corp (PRCT)
-
-
-
-
-
-
-
Real-World, Long-Term Data Demonstrate Sustained Benefits of Aquablation Therapy for Men with Benign Prostatic Hyperplasia
-
-
-
-
-
-
-
PROCEPT BioRobotics Corporation (PRCT) Reports First Commercial Aquablation Therapy Procedures in Japan
-
-
-
-
-
-
-
PROCEPT BioRobotics Reports Second Quarter 2022 Financial Results and Increases 2022 Revenue Guidance
-
-
-
-
335,203 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


